ロード中...
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
BACKGROUND: For acute myeloid leukemia (AML) patients, the role of bridging consolidation chemotherapy after achieving first complete remission (CR1) in the transplant setting is a frequently debated issue. The lack of data from Asian patients led us to conduct this study. METHODS: We retrospectivel...
保存先:
| 出版年: | Ther Adv Hematol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8060779/ https://ncbi.nlm.nih.gov/pubmed/33959243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20406207211001135 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|